| Recruiting | Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays NCT07283939 | Alliance for Clinical Trials in Oncology | N/A |
| Recruiting | A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Tras NCT07315750 | RemeGen Co., Ltd. | Phase 3 |
| Recruiting | The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patient NCT07139418 | Jichao Qin | — |
| Recruiting | Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine NCT07108855 | University Medical Center Groningen | Phase 1 / Phase 2 |
| Recruiting | Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematolog NCT07118176 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Recruiting | The Vanguard Study: Testing a New Way to Screen for Cancer NCT06995898 | National Cancer Institute (NCI) | N/A |
| Not Yet Recruiting | A Study of Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Che NCT06944496 | RemeGen Co., Ltd. | Phase 3 |
| Recruiting | A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or NCT06882746 | Boehringer Ingelheim | Phase 1 |
| Recruiting | PET-imaging of Two Vartumabs in Patients With Solid Tumors NCT06645808 | Var2 Pharmaceuticals | EARLY_Phase 1 |
| Recruiting | Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer NCT06408220 | City of Hope Medical Center | N/A |
| Recruiting | Analysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the NCT06728891 | Jichao Qin | — |
| Recruiting | Exploration of Lymph Node Metastasis and Tumor Deposit in the Posterior Gastric Mesentery for Distal Gastric C NCT06736847 | Jichao Qin | — |
| Recruiting | XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. NCT06792435 | Evopoint Biosciences Inc. | Phase 1 / Phase 2 |
| Recruiting | The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with NCT06702683 | Lin Liu | — |
| Unknown | Anxiety Before Non-cardiac Surgery in Adults NCT05596188 | RenJi Hospital | — |
| Active Not Recruiting | The Influence of Splenic Artery Characteristics in Gastric Cancer Surgery NCT06680362 | xiaohua li | — |
| Unknown | Immunohistochemical Evaluation of DNA Methylation and Histone Modification in H. Pylori Associated Gastric Car NCT05811546 | Assiut University | — |
| Unknown | Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis NCT05229809 | Jie Li | Phase 4 |
| Completed | Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Usin NCT06789224 | Lindis Bloodcare GmbH | N/A |
| Completed | Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic I NCT05083338 | M.D. Anderson Cancer Center | — |
| Completed | Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced NCT04505553 | University of Washington | Phase 2 |
| Active Not Recruiting | National Cancer Institute "Cancer Moonshot Biobank" NCT04314401 | National Cancer Institute (NCI) | — |
| Completed | The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gast NCT04602026 | Ohio State University Comprehensive Cancer Center | N/A |
| Unknown | Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma NCT04443036 | China Medical University, China | N/A |
| Terminated | A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer NCT04254107 | Seagen Inc. | Phase 1 |
| Active Not Recruiting | Telehealth for the Self-Management of Dietary Quality of Life in Patients After Stomach Cancer Surgery NCT05203627 | City of Hope Medical Center | N/A |
| Unknown | Patient-Derived Xenografts to Reduce Cancer Health Disparities NCT04410302 | University of California, Davis | — |
| Active Not Recruiting | Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal a NCT04147494 | Jonsson Comprehensive Cancer Center | EARLY_Phase 1 |
| Terminated | A Safety Study of SGN-CD47M in Patients With Solid Tumors NCT03957096 | Seagen Inc. | Phase 1 |
| Completed | Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer NCT03819088 | Emory University | N/A |
| Unknown | A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma NCT03735511 | Henan Cancer Hospital | — |
| Unknown | XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma NCT03599778 | Anhui Provincial Hospital | Phase 1 / Phase 2 |
| Withdrawn | Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, NCT03563352 | University of Southern California | — |
| Unknown | XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma NCT03355612 | Tianjin Medical University Cancer Institute and Hospital | Phase 3 |
| Active Not Recruiting | Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metapl NCT02782949 | National Cancer Institute (NCI) | Phase 2 |
| Unknown | A Study Evaluating MM-310 in Patients With Solid Tumors NCT03076372 | Merrimack Pharmaceuticals | Phase 1 |
| Unknown | CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor NCT02839954 | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Phase 1 / Phase 2 |
| Completed | Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors NCT02611024 | PharmaMar | Phase 1 / Phase 2 |
| Unknown | CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor NCT02617134 | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Phase 1 / Phase 2 |
| Active Not Recruiting | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymph NCT02465060 | National Cancer Institute (NCI) | Phase 2 |
| Unknown | A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer NCT02409199 | Shanghai Zhongshan Hospital | Phase 2 / Phase 3 |
| Withdrawn | Educational Brochure in Preparing Patients With Gastric Cancer and Their Caregivers for Recovery After Surgery NCT02334332 | City of Hope Medical Center | N/A |
| Unknown | Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96 NCT02317471 | Chinese PLA General Hospital | Phase 1 / Phase 2 |
| Unknown | A Registry Study on Shenqifuzheng（a Chinese Medicine Injection）Used in Hospitals in China NCT01812876 | China Academy of Chinese Medical Sciences | — |
| Completed | DNA Methylation Biomarkers and Metastasis of Gastric Carcinoma NCT02159339 | Peking University Cancer Hospital & Institute | — |
| Unknown | Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, a NCT01642797 | Shandong University | N/A |
| Unknown | Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer NCT01573468 | Genta Incorporated | Phase 2 |
| Unknown | Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer NCT01348009 | Genta Incorporated | Phase 1 / Phase 2 |
| Completed | Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer NCT00970138 | Fudan University | Phase 2 / Phase 3 |
| Unknown | Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carc NCT00639522 | Nanjing Sike Pharmaceutical Co., Ltd. | Phase 1 |
| Terminated | Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma NCT00256321 | University of California, Irvine | Phase 2 |